These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 15772744)

  • 1. Differences in MR features of the substantia innominata between dementia with Lewy bodies and Alzheimer's disease.
    Hanyu H; Tanaka Y; Shimizu S; Sakurai H; Iwamoto T; Abe K
    J Neurol; 2005 Apr; 252(4):482-4. PubMed ID: 15772744
    [No Abstract]   [Full Text] [Related]  

  • 2. Structural grey matter changes in the substantia innominata in Alzheimer's disease and dementia with Lewy bodies: a DARTEL-VBM study.
    Colloby SJ; Elder GJ; Rabee R; O'Brien JT; Taylor JP
    Int J Geriatr Psychiatry; 2017 Jun; 32(6):615-623. PubMed ID: 27197956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer's disease.
    Whitwell JL; Weigand SD; Shiung MM; Boeve BF; Ferman TJ; Smith GE; Knopman DS; Petersen RC; Benarroch EE; Josephs KA; Jack CR
    Brain; 2007 Mar; 130(Pt 3):708-19. PubMed ID: 17267521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MR features of the substantia innominata and therapeutic implications in dementias.
    Hanyu H; Shimizu S; Tanaka Y; Hirao K; Iwamoto T; Abe K
    Neurobiol Aging; 2007 Apr; 28(4):548-54. PubMed ID: 16569466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MR anatomy of the substantia innominata and findings in Alzheimer disease: a preliminary report.
    Sasaki M; Ehara S; Tamakawa Y; Takahashi S; Tohgi H; Sakai A; Mita T
    AJNR Am J Neuroradiol; 1995; 16(10):2001-7. PubMed ID: 8585486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer's disease and Lewy body dementia.
    Liberini P; Spano P; Cuello AC
    Br J Psychiatry; 1993 Nov; 163():693-4; author reply 694-5. PubMed ID: 8155133
    [No Abstract]   [Full Text] [Related]  

  • 7. MR analysis of the substantia innominata in normal aging, Alzheimer disease, and other types of dementia.
    Hanyu H; Asano T; Sakurai H; Tanaka Y; Takasaki M; Abe K
    AJNR Am J Neuroradiol; 2002 Jan; 23(1):27-32. PubMed ID: 11827872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cholinergic system in Alzheimer's disease and dementia with Lewy bodies: from animal models to neuropathological data.
    Liberini P
    Funct Neurol; 1997; 12(3-4):153-7. PubMed ID: 9218969
    [No Abstract]   [Full Text] [Related]  

  • 9. Is encroachment of the carotid termination into the substantia innominata associated with its atrophy and cognition in Alzheimer's disease?
    Gao FQ; Pettersen JA; Bocti C; Nestor SM; Kiss A; Black SE
    Neurobiol Aging; 2013 Jul; 34(7):1807-14. PubMed ID: 23414670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of basal forebrain atrophy in Alzheimer's disease using MRI.
    Teipel SJ; Flatz WH; Heinsen H; Bokde AL; Schoenberg SO; Stöckel S; Dietrich O; Reiser MF; Möller HJ; Hampel H
    Brain; 2005 Nov; 128(Pt 11):2626-44. PubMed ID: 16014654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing gray matter loss profiles between dementia with Lewy bodies and Alzheimer's disease.
    Ballmaier M; Memo M
    Funct Neurol; 2005; 20(2):69. PubMed ID: 15966269
    [No Abstract]   [Full Text] [Related]  

  • 12. Reduced substantia innominata volume mediates contributions of microvascular and macrovascular disease to cognitive deficits in Alzheimer's disease.
    Jaswal G; Swardfager W; Gao FQ; Nestor SM; Ganda A; Cogo-Moreira H; Sahlas DJ; Stuss DT; Moody A; Black SE
    Neurobiol Aging; 2018 Jun; 66():23-31. PubMed ID: 29505952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substantia innominata: MR findings in Parkinson's disease.
    Oikawa H; Sasaki M; Ehara S; Abe T
    Neuroradiology; 2004 Oct; 46(10):817-21. PubMed ID: 15316699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dementia in Parkinson's disease. Morphometric data.
    Duyckaerts C; Gaspar P; Costa C; Bonnet AM; Hauw JJ
    Adv Neurol; 1993; 60():447-55. PubMed ID: 8420169
    [No Abstract]   [Full Text] [Related]  

  • 15. Dementia with Lewy bodies: choline acetyltransferase parallels nucleus basalis pathology.
    Lippa CF; Smith TW; Perry E
    J Neural Transm (Vienna); 1999; 106(5-6):525-35. PubMed ID: 10443555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Striatal monoaminergic terminals in Lewy body and Alzheimer's dementias.
    Suzuki M; Desmond TJ; Albin RL; Frey KA
    Ann Neurol; 2002 Jun; 51(6):767-71. PubMed ID: 12112084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in magnetization transfer ratios of the hippocampus between dementia with Lewy bodies and Alzheimer's disease.
    Hanyu H; Shimizu S; Tanaka Y; Kanetaka H; Iwamoto T; Abe K
    Neurosci Lett; 2005 May 20-27; 380(1-2):166-9. PubMed ID: 15854771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropathological substrates of psychiatric symptoms in prospectively studied patients with autopsy-confirmed dementia with lewy bodies.
    Ballard CG; Jacoby R; Del Ser T; Khan MN; Munoz DG; Holmes C; Nagy Z; Perry EK; Joachim C; Jaros E; O'Brien JT; Perry RH; McKeith IG
    Am J Psychiatry; 2004 May; 161(5):843-9. PubMed ID: 15121649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dementia: Where are the Lewy bodies?].
    Lebouvier T; Delrieu J; Evain S; Pallardy A; Sauvaget A; Letournel F; Chevrier R; Lepetit M; Vercelletto M; Boutoleau-Bretonnière C; Derkinderen P
    Rev Neurol (Paris); 2013 Nov; 169(11):844-57. PubMed ID: 24103321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subcortical volume changes in dementia with Lewy bodies and Alzheimer's disease. A comparison with healthy aging.
    Watson R; Colloby SJ; Blamire AM; O'Brien JT
    Int Psychogeriatr; 2016 Apr; 28(4):529-36. PubMed ID: 26572170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.